Ipca Laboratories Ltd Quarterly Results

Gross Sales

2,246.69

2,245.37

2,354.9

2,092.63

2,033.03

Excise Duty

0

0

0

0

0

Net Sales

2,246.69

2,245.37

2,354.9

2,092.63

2,033.03

Other Operating Income

0

0

0

0

0

Other Income

25.82

20.11

26.26

20.61

18.92

Total Income

2,272.51

2,265.48

2,381.16

2,113.24

2,051.95

Total Expenditure

2,022.88

1,782.29

1,913.42

1,699.91

1,847.85

PBIDT

249.63

483.19

467.74

413.33

204.1

Interest

21.51

16.81

22.56

24.05

29.37

PBDT

228.12

466.38

445.18

389.28

174.73

Depreciation

100.12

98.46

100.35

98.89

98.13

Minority Interest Before NP

0

0

0

0

0

Tax

89.07

100.62

97.9

84.46

71.82

Deferred Tax

-26.85

-10.03

1.49

6.95

1.87

Reported Profit After Tax

65.78

277.33

245.44

198.98

2.91

Minority Interest After NP

-3.83

28.22

16.27

6.9

-58.26

Net Profit after Minority Interest

67.82

248.14

229.48

192.24

59.59

Extra-ordinary Items

-115.98

0

0

0

-63.03

Adjusted Profit After Extra-ordinary item

183.8

248.14

229.48

192.24

122.62

EPS (Unit Curr.)

2.67

9.78

9.05

7.58

2.35

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

200

0

0

Equity

25.37

25.37

25.37

25.37

25.37

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

11.11

21.51

19.86

19.75

10.03

PBDTM(%)

10.15

20.77

18.9

18.6

8.59

PATM(%)

2.92

12.35

10.42

9.5

0.14